Roche’s Evrysdi granted USFDA priority review for treatment of spinal muscular atrophy
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
The covid health center will be managed and administered by the district administration of Ballari
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
Subscribe To Our Newsletter & Stay Updated